A research team co-led by scientists at the University of Arizona College of Medicine—Tucson found that an osteoporosis drug ...

Non-invasive therapeutics for anti-osteoporosis treatment and fracture healing are available in both oral and injectable ...

The Osteoporosis Society of the Philippines Foundation Inc. (OSPFI) estimates that by 2050, around 10.2 million Filipinos ...

Celltrion’s two biosimilar treatments for treating osteoporosis and preventing bone metastasis complications in cancer ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

Bimagrumab, a drug originally developed for muscle loss, may help reduce the risk of osteoporosis in weight loss medication users by increasing bone tissue.

Alendronate has been shown to increase bone mineral density (BMD) and decrease fracture risk in postmenopausal women with osteoporosis, but the need for long-term treatment is unclear, especially ...

A new case report was published in Oncoscience's Volume 12 on February 4, 2025, titled “Breaking point: Systemic mastocytosis manifesting as severe osteoporosis.” ...

Vitamin D is vital for bone, muscle, and immune health but excessive intake can lead to serious health issues like ...

The FDA approved the denosumab biosimilar Ospomyv, interchangeable with Prolia, for preventing osteoporosis-related fracture ...

This report highlights the diagnostic challenges of SM, emphasize its underrecognized role in osteoporosis and fragility fractures, and advocates for ...